Published on in Vol 6, No 4 (2020): Oct-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/22521, first published .
Associations of Medications With Lower Odds of Typical COVID-19 Symptoms: Cross-Sectional Symptom Surveillance Study

Associations of Medications With Lower Odds of Typical COVID-19 Symptoms: Cross-Sectional Symptom Surveillance Study

Associations of Medications With Lower Odds of Typical COVID-19 Symptoms: Cross-Sectional Symptom Surveillance Study

Journals

  1. Peymani P, Dehesh T, Aligolighasemabadi F, Sadeghdoust M, Kotfis K, Ahmadi M, Mehrbod P, Iranpour P, Dastghaib S, Nasimian A, Ravandi A, Kidane B, Ahmed N, Sharma P, Shojaei S, Bagheri Lankarani K, Madej A, Rezaei N, Madrakian T, Los M, Labouta H, Mokarram P, Ghavami S. Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients. Translational Medicine Communications 2021;6(1) View
  2. Scheen A. Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies. Diabetes & Metabolism 2021;47(6):101220 View
  3. Camerino G, Tarantino N, Canfora I, De Bellis M, Musumeci O, Pierno S. Statin-Induced Myopathy: Translational Studies from Preclinical to Clinical Evidence. International Journal of Molecular Sciences 2021;22(4):2070 View
  4. Signorini C, Pignatti P, Coccini T. How Do Inflammatory Mediators, Immune Response and Air Pollution Contribute to COVID-19 Disease Severity? A Lesson to Learn. Life 2021;11(3):182 View
  5. Denis F, Fontanet A, Le Douarin Y, Le Goff F, Jeanneau S, Lescure F. A Self-Assessment Web-Based App to Assess Trends of the COVID-19 Pandemic in France: Observational Study. Journal of Medical Internet Research 2021;23(3):e26182 View
  6. Ikari Y, Matsue Y, Torii S, Hasegawa M, Aihara K, Kuroda S, Sano T, Kitai T, Yonetsu T, Kohsaka S, Kishi T, Komuro I, Hirata K, Node K, Matsumoto S. Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors. Circulation Journal 2021;85(6):939 View
  7. Yuvanc E, Tuglu D, Ozan T, Kisa U, Balci M, Batislam E, Yilmaz E. Evaluation of pheniramine maleate and zofenopril in reducing renal damage induced by unilateral ureter obstruction. An experimental study. Archives of Medical Science 2021;17(3):812 View
  8. Bakhtiari M, Asadipooya K. Metainflammation in COVID-19. Endocrine, Metabolic & Immune Disorders - Drug Targets 2022;22(12):1154 View